Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 7. Annual reported cases of notifiable diseases and rates per 100,000 population, by ethnicity*, excluding U.S. Territories - - United States, 2018
Disease Hispanic Non-Hispanic Ethnicity not stated Total
No. Rate No. Rate No. No.
Anthrax S S S S S 1
Arboviral diseases
Chikungunya virus disease 11 0.02 67 0.03 39 117
Eastern equine encephalitis virus disease
Neuroinvasive S S S S S 6
Non-neuroinvasive
Jamestown Canyon virus disease
Neuroinvasive 1 0.00 16 0.01 8 25
Non-neuroinvasive S S S S S 16
La Crosse virus disease
Neuroinvasive 3 0.01 51 0.02 29 83
Non-neuroinvasive S S S S S 3
Powassan virus disease
Neuroinvasive S S S S S 21
Non-neuroinvasive
St. Louis encephalitis virus disease
Neuroinvasive S S S S S 5
Non-neuroinvasive S S S S S 3
West Nile virus disease
Neuroinvasive 150 0.25 1,038 0.39 469 1,657
Non-neuroinvasive 46 0.08 616 0.23 327 989
Western equine encephalitis virus disease
Neuroinvasive
Non-neuroinvasive
Babesiosis
Total 240 0.45 1,225 0.56 695 2,160
Confirmed 221 0.42 1,046 0.48 594 1,861
Probable 19 0.04 179 0.08 101 299
Botulism
Total 52 0.09 117 0.04 56 225
Foodborne S S S S S 17
Infant 34 3.37 83 2.92 40 157
Other (wound & unspecified) 15 0.03 25 0.01 11 51
Brucellosis 56 0.09 56 0.02 26 138
Campylobacteriosis 8,626 14.41 39,542 14.79 22,032 70,200
Chancroid S S S S S 3
Chlamydia trachomatis infection 231,398 386.49 862,464 322.66 664,806 1,758,668
Cholera S S S S S 14
Coccidioidomycosis  2,531 9.93 4,089 3.74 8,991 15,611
Cryptosporidiosis
Total 1,149 1.92 8,187 3.06 3,197 12,533
Confirmed 887 1.48 5,785 2.16 2,308 8,980
Probable 262 0.44 2,402 0.90 889 3,553
Cyclosporiasis 500 0.88 2,201 0.93 818 3,519
Dengue virus infections §
Dengue 104 0.17 200 0.07 120 424
Dengue-like illness 4 0.01 26 0.01 11 41
Severe dengue S S S S S 9
Diphtheria S S S S S 1
Ehrlichiosis and Anaplasmosis
Anaplasma phagocytophilum infection 115 0.20 2,511 0.97 1,382 4,008
Ehrlichia chaffeensis infection 56 0.10 1,246 0.48 497 1,799
Ehrlichia ewingii infection 1 0.00 27 0.01 5 33
Undetermined ehrlichiosis/anaplasmosis 7 0.01 227 0.09 49 283
Giardiasis 1,268 2.87 7,726 3.64 6,554 15,548
Gonorrhea 68,326 114.12 346,760 129.73 168,319 583,405
Haemophilus influenzae, invasive disease
All ages, all serotypes 324 0.54 3,793 1.42 1,456 5,573
Age <5 years
Serotype b 6 0.12 21 0.14 11 38
Non-b serotype 24 0.46 129 0.88 38 191
Nontypeable 32 0.62 141 0.96 49 222
Unknown serotype 34 0.66 106 0.72 35 175
Hansen's disease 14 0.02 41 0.02 35 90
Hantavirus infection, non-hantavirus pulmonary syndrome S S S S S 2
Hantavirus pulmonary syndrome S S S S S 18
Hemolytic uremic syndrome post-diarrheal 48 0.08 258 0.10 70 376
Hepatitis 
A, acute 417 0.70 8,450 3.16 3,607 12,474
B, acute 227 0.38 2,383 0.90 712 3,322
B, perinatal infection S S S S S 23
C, acute 341 0.60 3,298 1.30 1,129 4,768
Confirmed 292 0.51 2,456 0.97 873 3,621
Probable 49 0.09 842 0.33 256 1,147
C, perinatal infection 13 0.03 84 0.03 117 214
Human immunodeficiency virus diagnoses 8,216 13.72 24,783 9.27 32,999
Influenza-associated pediatric mortality 35 0.19 100 0.18 24 159
Invasive pneumococcal disease **
All ages 1,383 3.57 12,904 6.29 5,570 19,857
Confirmed 1,355 3.50 12,763 6.22 5,501 19,619
Probable 28 0.07 141 0.07 69 238
Age <5 years 154 0.37 684 0.31 278 1,116
Confirmed 145 3.99 667 5.45 266 1,078
Probable 9 0.25 17 0.14 12 38
Legionellosis 646 1.08 7,110 2.66 2,177 9,933
Leptospirosis 6 0.01 52 0.02 33 91
Listeriosis 114 0.19 601 0.22 149 864
Lyme disease
Total 499 0.84 13,752 5.17 19,415 33,666
Confirmed 351 0.59 9,200 3.46 14,007 23,558
Probable 148 0.25 4,552 1.71 5,408 10,108
Malaria 28 0.05 1,232 0.46 488 1,748
Measles
Total 8 0.01 319 0.12 48 375
Indigenous 5 0.01 257 0.10 34 296
Imported 3 0.01 62 0.02 14 79
Meningococcal disease
All serogroups 44 0.07 227 0.08 56 327
Serogroups ACWY 15 0.03 72 0.03 13 100
Serogroup B 6 0.01 59 0.02 16 81
Other serogroups 20 0.01 3 23
Unknown serogroup 23 0.04 76 0.03 24 123
Mumps 514 0.86 1,282 0.48 719 2,515
Novel Influenza A virus infections S S S S S 14
Paratyphoid fever †† 6 0.01 86 0.03 41 133
Pertussis 2,335 3.90 10,014 3.75 3,260 15,609
Plague S S S S S 1
Poliomyelitis, paralytic
Poliovirus infection, nonparalytic
Psittacosis S S S S S 22
Q fever
Total 36 0.06 129 0.05 50 215
Acute 34 0.06 105 0.04 39 178
Chronic 2 0.00 24 0.01 11 37
Rabies
Human S S S S S 3
Rubella S S S S S 4
Rubella, congenital syndrome
Salmonellosis (excluding paratyphoid fever and typhoid fever) §§ 9,141 15.27 36,641 13.71 15,217 60,999
Severe acute respiratory syndrome-associated coronavirus disease
Shiga toxin-producing Escherichia coli (STEC) 2,957 4.94 9,454 3.54 3,585 15,996
Shigellosis 3,657 6.11 8,915 3.34 3,761 16,333
Smallpox
Spotted fever rickettsiosis
Total 137 0.23 3,887 1.46 1,520 5,544
Confirmed 7 0.01 79 0.03 38 124
Probable 130 0.22 3,808 1.44 1,482 5,420
Streptococcal toxic shock syndrome 30 0.12 288 0.16 53 371
Syphilis
Total, all stages ¶¶ 30,124 50.31 75,851 28.38 9,070 115,045
Congenital 411 46.38 846 29.46 49 1,306
Primary and secondary 7,663 12.80 24,965 9.34 2,435 35,063
Tetanus S S S S S 23
Toxic shock syndrome (other than Streptococcal) 2 0.01 22 0.01 9 33
Trichinellosis S S S S S 1
Tuberculosis 2,617 4.37 6,373 2.38 35 9,025
Tularemia 11 0.02 177 0.07 41 229
Typhoid fever 50 0.08 268 0.10 83 401
Vancomycin-intermediate Staphylococcus aureus 3 0.01 41 0.02 41 85
Vancomycin-resistant Staphylococcus aureus
Varicella morbidity 1,392 2.61 4,824 2.25 1,985 8,201
Varicella mortality U U U U U U
Vibriosis
Total 330 0.56 1,896 0.72 738 2,964
Confirmed 182 0.31 1,231 0.47 409 1,822
Probable 148 0.25 665 0.25 329 1,142
Viral hemorrhagic fevers
Crimean-Congo hemorrhagic fever virus
Ebola virus
Guanarito virus
Junin virus
Lassa virus
Lujo virus
Machupo virus
Marburg virus
Sabia virus
Yellow fever
Zika virus
Zika virus disease, congenital *** S S S S S 2
Zika virus disease, non-congenital 42 0.07 12 0.00 25 79
Zika virus infection, congenital *** S S S S S 8
Zika virus infection, non-congenital 137 0.23 58 0.02 50 245
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • U: Unavailable — The data are unavailable.
  • S: Suppressed
  • * Conditions with <25 cases reported in the year were not broken down by ethnicity.
  • † Reportable in <25 states.
  • § Counts include confirmed and probable dengue cases.
  • ¶ Chronic hepatitis B and C data are not included in NNDSS tables but reported case counts are included in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm.
  • ** Counts include drug resistant and susceptible cases of Invasive Pneumococcal Disease. This condition was previously named Streptococcus pneumoniae invasive disease and cases were reported to CDC using different event codes to specify whether the cases were drug resistant or in a defined age group, such as <5 years.
  • †† Prior to 2018, cases of paratyphoid fever were considered salmonellosis.
  • §§ Prior to 2018, cases of paratyphoid fever were included as salmonellosis, but beginning in 2018 they are being published as paratyphoid fever.
  • ¶¶ Includes the following categories: primary; secondary; early non-primary non-secondary (includes cases previously reported as early latent); and unknown duration or late (includes cases previously reported as late latent syphilis and cases previously reported as late syphilis with clinical manifestations).
  • *** Data reported to ArboNET using the national surveillance case definition for congenital Zika virus infection (CSTE Position Statement 16-ID-01).

TOP